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http://dx.doi.org/10.1016/j.stemcr.2017.05.017SUMMARYMicroglia are increasingly implicated in brain pathology, particularly neurodegenerative disease, with many genes implicated in
Alzheimer’s, Parkinson’s, and motor neuron disease expressed in microglia. There is, therefore, a need for authentic, efficient
in vitro models to study human microglial pathological mechanisms. Microglia originate from the yolk sac as MYB-independent
macrophages, migrating into the developing brain to complete differentiation. Here, we recapitulate microglial ontogeny by highly
efficient differentiation of embryonic MYB-independent iPSC-derived macrophages then co-culture them with iPSC-derived cortical
neurons. Co-cultures retain neuronal maturity and functionality for many weeks. Co-culture microglia express key microglia-specific
markers and neurodegenerative disease-relevant genes, develop highly dynamic ramifications, and are phagocytic. Upon activation
they become more ameboid, releasing multiple microglia-relevant cytokines. Importantly, co-culture microglia downregulate path-
ogen-response pathways, upregulate homeostatic function pathways, and promote a more anti-inflammatory and pro-remodeling
cytokine response than corresponding monocultures, demonstrating that co-cultures are preferable for modeling authentic microglial
physiology.INTRODUCTION
Microglia are brain-resident macrophages, with important
homeostatic functions that provide a supportive environ-
ment to neurons. This includes pruning incompetent syn-
apses during development, and clearance of dead cells,
misfolded proteins, and other cellular debris (Ransohoff,
2016). However, they can become activated by inflamma-
tory stimuli, producing a battery of cytokines, including
the potentially damaging tumor necrosis factor a (TNFa).
If not satisfactorily resolved, this response can lead to a
chronically damaging cycle of activation and neuronal
destruction. Numerous genes associated with Alzheimer’s
disease (AD), Parkinson’s disease (PD), motor neuron dis-
ease/amyotrophic lateral sclerosis (MND/ALS), and fronto-
temporal dementia (FTD) are expressed in microglia,
including TREM2, CD33, LRRK2, and C9orf72 (O’Rourke
et al., 2016; Russo et al., 2014; Villegas-Llerena et al.,
2016), prompting a growing interest in microglia biology
and their relevance to neurodegenerative disease.Stem Cell R
This is an open access artiStudy of microglia has been largely restricted to non-
human models (mostly mouse), since availability of fresh
primary human microglia is very limited and they cannot
be propagated. Moreover, microglia rapidly lose their
unique identity when removed from the brain environ-
ment and cultured in monoculture in vitro (Butovsky
et al., 2014). Transformed microglial-like cell lines are by
definition highly proliferative and therefore not a good
model for understanding a predominantly non-prolifer-
ating, differentiated cell type. There is therefore a need
for practical, authentic human microglial cellular models.
However, only recently has the ontogeny of microglia
been established to inform appropriate modeling.
In mice, two waves of embryonic macrophages are pro-
duced in the yolk sac blood islands at embryonic day 7.5
(E7.5) and E8.25, and the first wave migrate into the
developing brain and differentiate to microglia (Ginhoux
et al., 2010; Gomez Perdiguero et al., 2015; Hoeffel et al.,
2015; Palis et al., 1999). These yolk sac-derived macro-
phages are Myb independent but dependent on PU.1 andeports j Vol. 8 j 1727–1742 j June 6, 2017 j ª 2017 The Author(s). 1727
cle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Irf8 (Kierdorf et al., 2013; Schulz et al., 2012). Hemato-
poietic stem cells (HSCs), in contrast, derive from the
aorto-gonado-mesonephros region at day E10.5, populate
the fetal liver and bonemarrow, and give rise to adult blood
cells from HSCs in bone marrow niches, which are depen-
dent on Myb for their renewal. Myb independence, there-
fore, distinguishes yolk sac-derived macrophages from
adult, definitive, blood monocyte-derived macrophages.
Microglia in the developing brain proliferate locally at a
low rate and are not normally replaced by othermonocytes
and macrophages from outside the brain, in contrast
to most other tissue-resident macrophages (which also
initially originate from yolk sac-derived macrophages, but
are partially or fully replaced by fetal liver- or blood mono-
cyte-derived macrophages [Bain et al., 2014; Calderon
et al., 2015; Epelman et al., 2014; Guilliams et al., 2014;
Hoeffel and Ginhoux, 2015; Tamoutounour et al., 2013]).
In the brain, interleukin-34 (IL-34) is an alternative
CSF1R ligand supporting microglia survival and differenti-
ation (Greter et al., 2012), and microglia adopt an increas-
ingly ramified morphology and continued maturation far
beyond birth.
In humans there are few opportunities to investigate the
ontogeny of microglia, but it is assumed that the processes
are analogous to those in mice. Yolk sac-derived macro-
phages appear at E17 (Tavian and Peault, 2005), enter the
brain from E31 onward (Rezaie et al., 2005; Monier et al.,
2007), andmature together withneurons to fully functional
ramified microglia (Figure 1A). Human cortical neurons
show spontaneous electrical activity after microglia inva-
sion, from gestation week 20 onwards (Moore et al., 2011).
We aimed to recapitulate the in vivo developmental
pathway of microglia in vitro, using human induced
pluripotent stem cells (iPSCs). These have the advantages
of limitless self-renewal and normal karyotype, and can
be directed to terminally differentiated cell types. They
can be derived from patients (retaining the patient’s
genetic background) and are amenable to gene editing,
enabling sophisticated interrogation of genes of interest.
To recapitulate the development of yolk sac-derived
macrophages, we use our previously established, straight-
forward, highly efficient, serum- and feeder-free protocol
for deriving PSC macrophages (Karlsson et al., 2008; van
Wilgenburg et al., 2013). We have recently directly demon-
strated that these derive from MYB-independent, RUNX1-
and PU.1-dependent precursors, characteristic of yolk
sac-derived macrophages (Buchrieser et al., 2017; Vanhee
et al., 2015). Here, we co-culture them with iPSC cortical
neurons (Shi et al., 2012), in medium optimized for sur-
vival and functionality of both neurons and microglia.
The resulting co-cultures are stable formanyweeks, express
relevant microglia markers (including key disease-related
genes), upregulate pathways relating to homeostatic func-1728 Stem Cell Reports j Vol. 8 j 1727–1742 j June 6, 2017tions, and downregulate pathogen-response pathways.
They are phagocytic, display highly dynamic ramifications,
respond to activation by clustering and adoption of
ameboid morphology, and produce cytokine profiles that
are specific to co-culture versus monoculture.RESULTS
iPSC-Derived Embryonic Macrophages Co-cultured
with iPSC-Derived Neurons Recapitulate Microglial
Development in the Embryo
To recapitulate the development of microglia in the em-
bryo (Figure 1A), we used our previously established pro-
tocol (van Wilgenburg et al., 2013) to generate embry-
onic-like, MYB-independent macrophage precursors from
iPSCs from four different donors (Table S1). Defined-
size embryoid bodies (EBs) are formed using Aggrewells
(STEMCELL Technologies), cultured with bone morphoge-
netic protein 4 (BMP4; to induce mesoderm), vascular
endothelial growth factor (VEGF; endothelial precursors),
and stem cell factor (SCF; hematopoietic precursors), then
plated into large-format flasks with IL-3 and macrophage
colony-stimulating factor (M-CSF) to promote myeloid
differentiation. Most EBs adhere, put out surrounding
adherent stromal cells, and develop cystic, yolk-sac-like
structures. After 3–4 weeks, embryonic-like macrophage
precursors emerge into the supernatant as a uniform popu-
lation of large, round cells with obvious filopodia and ruf-
fles. Originally termed ‘‘monocytes’’ (Karlsson et al., 2008;
van Wilgenburg et al., 2013), we now understand their
ontogeny to be MYB-independent primitive myeloid cells
(Buchrieser et al., 2017), so they aremore accurately termed
macrophage precursors (pMacpre, Figure 1B). These can
simply be harvested by collecting the supernatant without
disrupting the EBs and replenishing flasks with fresh me-
dium for many subsequent weekly harvests. The cumula-
tive yield of pMacpre for the lines used in this study was
10- to 43-fold higher than the number of input iPSCs,
consistent with yields previously reported for this protocol
(van Wilgenburg et al., 2013), similar to a recently pub-
lished hiPS-microglia protocol (typically 40-fold) (Abud
et al., 2017), and 10-fold higher than two other recently
published hiPS-microglia protocols (0.5- to 4-fold and
0.8- to 3-fold yields relative to input iPSCs, respectively)
(Muffat et al., 2016; Pandya et al., 2017).
To mimic the subsequent seeding of embryonic macro-
phages into the developing brain, we co-cultured harvested
pMacpre with iPSC-derived cortical neurons (Shi et al.,
2012) (Figure 1C). We designed the co-culture medium to
maintain microglia survival, which is dependent on
signaling through the tyrosine kinase receptor CSF1, so
we included the CSF1R ligand IL-34 (the alternative CSF1
Figure 1. iPSC-Derived Microglia-Neuron Co-culture Recapitulates Microglial Development in the Embryo
(A) Human microglia originate from the yolk sac as primitive macrophages, migrating into the fetal brain before the formation of the
blood-brain barrier, and completing their maturation in the brain environment.
(B) Acronyms used for the cell types in this study.
(C) Co-culture of iPSC embryonic macrophages and iPSC-cortical neurons with IL-34 (and, optionally, low level GM-CSF) recapitulates
development of microglia in the brain. White arrows: highly ramified cells most evident in dense neuron clusters.
(D) Ramified microglia after 2 weeks of co-culture.
Black scale bars, 200 mm; white scale bars, 50 mm. See also Figures S1 and S2; Movie S1.
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Figure 2. iPSC Co-culture Microglia Express Consensus Microglia Markers
Illumina HT12v4 transcriptome analysis of blood monocytes (bloodMono), iPSC-derived macrophage precursors (pMacpre), iPSC-derived
macrophages (pMac), iPSC macrophages in microglia medium (pMGL), iPSC co-culture microglia isolated from co-culture (co-pMG), and
freshly isolated human primary fetal microglia (fetalMG) (three genetic backgrounds each).
(A) Principal component (PC) analysis of samples based on protein coding gene expression. Numbers in parentheses indicate the per-
centage variance.
(B) Cell type analysis. Samples are hierarchically clustered by their expression of metagenes defined by non-negative matrix factorization
from a previously published expression dataset for human cortex myeloid cells, cortical oligodendrocytes, astrocytes, neurons, and
endothelial cells (Zhang et al., 2016). Red asterisks indicate significant clusters (pvclust, approximately unbiased).
(C) Expression of consensus human microglia/monocyte markers. Genes found by Melief et al. (2012) to be highest in microglia are
highlighted in green on left-hand bar; six genes identified as being differentially expressed in microglia versus blood monocytes by
Butovsky et al. (2014) are magenta, and TMEM119 (Bennett et al., 2016), is azure. Rows are hierarchically clustered.
(D) Expression of key microglia markers by qRT-PCR. Fold change was calculated using the DDCT method, with 18S RNA as an endogenous
control and normalization to bloodMono. Three genetic backgrounds for all conditions, as per transcriptome samples, with additional
comparison with cultured adult human microglia (n = 1, with technical PCR triplicates) and with directly isolated/processed adult human
(legend continued on next page)
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ligand produced in the brain, M-CSF being the main
ligand in the periphery). We also sought compatibility
with iPSC cortical neurons in culture, but aimed to reduce
the presence of components in neuronal media that
might compromise microglia function, so the neuronal
supplement B27 was not included as it contains corticoste-
rone, superoxide dismutase (SOD), and catalase. Finally, in
pilot experiments, we tested the ability of different media
and growth factors to induce ramified microglia-like
morphology in our macrophages, following previous evi-
dence that astrocyte-derived granulocyte M-CSF (GM-
CSF), M-CSF, and transforming growth factor b (TGFb)
can each induce ramified morphology in microglia (Schil-
ling et al., 2001), and that IL-34 and GM-CSF can ramify
blood monocytes (Etemad et al., 2012; Ohgidani et al.,
2014). Advanced DMEM/F12 with N2 and 100 ng/mL IL-
34 satisfied the requirement for CSF1R engagement and
neuronal compatibility, while IL-34 with (optional) low-
dose GM-CSF (10 ng/mL) induced the most ramified
morphology (Figures S1A–S1D), so this microglia medium
was used for all subsequent experiments (Table S2). In
microgliamedium and in co-culture with iPSC cortical neu-
rons (pNeurons), pMacpre adopted ramified microglial
morphology with secondary branching within 2 weeks
(Figures 1C and 1D). They are referred to hereafter as co-cul-
ture PSC microglia, or co-pMG. PSC macrophages are
termed pMac, unless cultivated in microglia medium (as
monocultures), when they are termed PSC microglia-like
cells, pMGL.
Co-culture Is Compatible with iPSC Cortical Neuronal
Maturation and Function
Co-culture could be extended for at least 42 days, during
which time neurons maintained spontaneous electrical
activity at least as well as neurons cultured alone (Fig-
ure S1E), and calcium flux was observable upon addition
of potassium ions (Movie S1). Pre- and postsynaptic
markers (Synaptophysin and PSD95) were observable in
neuronal monocultures and in co-cultures (Figures S1F
and S1G). Neuronal progenitors present in the cultures
continued to proliferate, leading to an increase in the den-
sity of the cultures, whereas proliferation, as assessed by Ki-
67 staining, was very low in co-pMG (similar to pMGL and
pMac, Figures S1H–S1K). For this reason, most assays were
conducted after 2 weeks of co-culture. Nonetheless, co-
pMG persisted within the extended-duration cultures,
maintaining expected density to at least day 39 (Figure S2).
Co-pMG were dependent on CSF1R ligand delivery in themicroglia (n = 1, technical PCR triplicates). A second set of bloodMo
markers, alongside a second batch of pMac (three genetic backgrou
parisons test versus bloodMono. *p < 0.05, **p < 0.01, ***p < 0.001
See Figures S3 and S4 for further transcriptomic analyses.culturemedium for persistence in co-culture, as withdrawal
of IL-34 led to depletion of co-pMG (data not shown).
Finally, co-culture neurons expressed both deep-layer
(TBR1) and upper-layer (SatB2) cortical identity markers
(Figure S2). Together, these observations indicate that co-
culture conditions were compatible for co-pMG and had
no detrimental effect on the maturity and functionality
of the neurons.
Transcriptome Analysis Demonstrates a Microglial
Signature in iPSC Co-culture Microglia
To assess to what extent the co-cultured cells resembled
microglia, we isolated co-pMG from the neuronal culture
using CD11b magnetic beads and compared their tran-
scriptome with human fetal microglia (fetalMG), pMGL,
pMac, pMacpre, and fresh adult blood-derived monocytes
(bloodMono).
Based on their first two principal components, the sam-
ples separated into three distinct groups comprised of (1)
bloodMono, (2) pMacpre, and (3) pMac, pMGL, co-pMG,
and fetalMG (Figure 2A). The bloodMono and pMacpre
samples showed an orthogonal separation from the
macrophage and microglia samples that is in line with
the different developmental origins of these cells. To
investigate this possibility, we identified the set of genes
significantly differentially expressed between these two
populations (Figure S3 and Table S3). FLT3, a marker of
definitive hematopoiesis, showed higher expression in
the bloodMono samples (5.5-fold, adjusted p < 2.4 3
108), along with several HLA genes, in agreement with
blood monocytes exposure to priming cytokines in the
blood and their role in antigen presentation to T cells.
MeanwhileMAF, a known marker of primitive hematopoi-
esis, showed higher expression in pMacpre (21.7-fold,
adjusted p < 7.83 107). APOE, variants of which aremajor
risk factors for AD, was among the most strongly differen-
tially expressed genes, being very low in bloodMono and
high in all other populations (Figure S3A).
Comparison with a previously published expression da-
taset for cells derived from human brain tissue (Zhang
et al., 2016) showed that all the cell types in the current
study cluster with human cortex myeloid cells and not
with cortical oligodendrocytes, astrocytes, neurons, or
endothelial cells (Figure 2B).
As a set, genes previously identified to be associated spe-
cifically with microglia but not with blood monocytes
(Bennett et al., 2016; Butovsky et al., 2014; Melief et al.,
2012) (Figure 2C) showed similar expression in co-pMGno were also differentiated to macrophages and assessed for these
nds each). Mean ± SEM, one-way ANOVA, Dunnett’s multiple com-
, ****p < 0.0001.
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and fetalMG. Most notably, the six key microglia-specific
genes identified by Butovsky et al. (2014), MERTK,
GPR34, PROS1, C1QA, GAS6, and P2RY12, were all
strongly expressed in co-pMG, whereas bloodMono poorly
expressed most of these markers (highlighted in magenta,
Figure 2C) These expression profiles were confirmed by
qRT-PCR (Figure 2D), which also showed that co-pMG
had comparable levels of expression of these microglial
genes with cultured adult human microglia and with
directly processed adult human microglia, and that while
blood monocyte-derived macrophages also upregulated
several of these genes, they mostly did not reach the
same expression level. Notably, pMacpre, pMac, and
pMGL also expressed high levels of most of these genes,
along with many of those identified byMelief et al. (2012).
Next, we investigated the difference between the iPSC-
derived macrophage and microglia populations. A tar-
geted principal components analysis of these samples re-
vealed a weak neural cell signature in the co-cultured
pMG isolated with CD11b beads, but otherwise demon-
strated the close similarity of these cells to fetal microglia
(Figures S4A and S4B). We then sought to better under-
stand the transcriptional differences between the differen-
tiated PSC-derived samples pMac, pMGL, and co-pMG.
We focused on genes with high and significantly variable
expression using k-means clustering to identify five
distinct signatures of gene expression (Figure S4C).
Gene ontology analysis identified biological processes
with significant enrichment in these gene sets, demon-
strating that co-pMG downregulate genes in pathways
associated with type I interferon responses (involved in
antiviral responses), Toll-like receptor 1 (TLR1) and TLR2
signaling (bacterial and yeast recognition), and antigen
presentation, relative to the monoculture populations.
This implies that co-culture with neurons downregulates
responses to external pathogens. Meanwhile, genes upre-
gulated in co-pMG were enriched for biological processes
including differentiation, chemotaxis/migration, regula-
tion of cell-cell adhesion, and metal ion response
(Hancock et al., 2014), all of which would be important
for microglia to carry out their homeostatic surveillance
and clearing functions.
Taken together, these results show the transcriptomic
similarity of co-pMG with primary microglia, with expres-
sion of key microglial markers and genes in relevant
homeostatic pathways, and downregulation of antimicro-
bial pathways in co-pMG. However, these results also high-
light a previously unappreciated detail, which is that genes
that have been previously identified as being specific to
microglia versus blood monocytes are not necessarily
exclusive to microglia, but a subset of them are more likely
correlates of primitive macrophages, since they are also
highly expressed in pMac.1732 Stem Cell Reports j Vol. 8 j 1727–1742 j June 6, 2017Co-culture Microglia Express Genes Associated with
Major Neurodegenerative Disease
Because numerous genes associated with AD, PD, MND/
ALS, and FTD (through acquisition of mutations or SNP
variants) have been found to be expressed in microglia,
we examined the expression of these genes in our transcrip-
tome dataset (Figure 3). FERMT2, TREM2, APOE, and
UCHL1 were expressed in fetalMG and co-pMG but not
in bloodMono (although TREM2was upregulated in blood-
Mono-derived macrophages, Figure 2D). Other key AD-
related genes expressed in fetalMG and co-pMG (and
bloodMono) included APP, PICALM, and CD33; PD-related
genes included PARK15, PINK1, SNCA, andDJ-1; andMND-
related genes included C9orf72, TDP43, and SOD1. Note
that almost all of these genes were also expressed in
pMacpre, pMac, and pMGL. Together, this shows that our
co-culture system is a relevant model to study the effects
of numerous genes associated with neurodegenerative dis-
ease, and that monoculture pMac or pMGL can be useful
for answering specific disease gene-related questions where
co-culture is impractical.
Co-culture Microglia Express Macrophage-/Microglia-
Relevant Proteins
We next sought evidence for the functional protein pro-
ducts of key microglia genes. Flow cytometry with directly
conjugated antibodies showed CD11b (integrin alpha M, a
marker for mature myeloid cells and a subunit of the com-
plement receptor, CR3, also known as Mac-1), CD14 (a
component of the receptor for bacterial lipopolysaccharide
[LPS]), and CD45 (a pan-leukocyte marker and tyrosine
phosphatase which dephosphorylates several receptor
tyrosine kinases), were expressed on all PSC-derivedmacro-
phage and microglia (Figures 4A and 4B). CD11c (integrin
alpha X, part of the inactivated-C3b receptor 4, CR4), was
well expressed in monoculture cells, but weakly expressed
in co-pMG. HLA-DR (a major histocompatibility complex
[MHC] class II antigen) was undetectable in any PSC-
derived myeloid lineages, reflecting the unprimed culture
conditions. The microglia-associated protein MERTK was
expressed highly on all PSC-derived macrophage and mi-
croglia conditions, while the AD-associated protein CD33
was detected albeit at low levels. An unconjugated poly-
clonal antibody to TMEM119 gave modest staining of
pMGL but background staining was evident in co-culture
cells, and an unconjugated antibody to the purinergic re-
ceptor P2YR12 showed strong staining of pMGL although
background staining was similarly evident in co-culture
(Figure S5). These markers did not increase in a consistent
way during the time course of the co-cultures (Figures
S5C–S5E). IBA1 (a cytoplasmic calcium-binding protein
associated with myeloid cells, particularly microglia) was
readily detectable in co-pMG by immunocytochemistry
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Figure 3. Expression of Genes Associated
with Major Neurodegenerative Disorders
Samples and expression dataset as per
Figure 2.(Figures 1B and 1C). These results show that co-pMG and
their primitive precursors express expected microglia and
myeloid-associated proteins, although PSC macrophages
and microglia have not been exposed to the cytokine
milieu of the body and thus have low basal levels of pro-
teins such as MHC antigens.
Co-culture Promotes Microglial Ramification and
Motility
To identify and image microglia live in co-culture, we used
co-pMG differentiated from an iPSC line containing mul-
tiple copies of an integrated lentivector containing theRFP gene under the control of the constitutively active
EF-1a promoter. Co-pMG roughly ‘‘tile’’ within the
neuronal culture, making direct contacts with the neurons
(Figure 5A). Live imaging revealed a dynamically remod-
eled ramified morphology, every 5-min and even 12-s
frame revealing changes to primary and secondary branch-
ing (Movies S2 and S3). Co-pMG moved constantly, most
of them roughly maintaining their territories. Quantifica-
tion of movement of co-pMG, pMGL, and pMac over
5 hr showed co-pMG moved a significantly greater accu-
mulated distance (251 ± 21 mm; mean ± SEM; n = 6) than
pMGL (119 ± 6 mm; n = 5) and pMac (53 ± 11 mm; n = 5),Stem Cell Reports j Vol. 8 j 1727–1742 j June 6, 2017 1733
(legend on next page)
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which hardly moved at all (Figures 5B–5F). Together, these
results show that co-pMG display the morphology and dy-
namic behavior expected of microglia, continually sensing
and responding to their neuronal environment. These fea-
tures were a direct result of physical contact with neurons,
as cells monocultured on tissue-culture plastic did not
display such dynamic microglial characteristics.
Co-culture Microglia Are Phagocytically Competent
We have previously demonstrated that pMac are compe-
tent at phagocytosing particles, progressive acidification
of the maturing phagosome being detectable using par-
ticles coupled to pH-sensitive fluorophores (Kapellos
et al., 2016). pH-sensitive fluorescent zymosan particles
added to co-cultures became visible inside co-pMG,
within 1 hr, comparable with pMac (Movie S4), indi-
cating the competent development of mature phago-
somes in co-pMG.
iPSC Microglia Display Co-culture-Specific
Inflammatory Responses
To explore the ability of co-pMG to respond physically to
inflammatory signals, we stimulated co-cultures with LPS
and imaged them over the next 20 hr. Unstimulated co-
pMG retained roughly territorial surveillance behavior
over the whole imaging period (Movie S5), suggesting no
imaging-induced activation. In contrast, within 5 hr LPS-
stimulated co-pMG migrated to form clusters, and some
microglia had reduced ramifications and increased area-
to-perimeter ratio, indicative of transition to activated,
ameboid microglia (Figures 6A–6C and Movie S5). Clus-
tering was measured as distance to nearest neighbor,
showing a leftward shift (i.e., smaller distance) in curves
for LPS-treated cultures, indicative of the clustering clearly
observable by eye (Figure 6D). Blindedmorphology scoring
showed a significant increase in the proportion of cells
with activated morphology in LPS-treated cultures in six
analyzed videos (time point mean ± SEM: 0 hr, 4.1 ± 0.6;
10 hr, 7.6 ± 1.1; 20 hr, 8.1 ± 0.8; Figure 6E).
To examine the cytokine responses of co-pMG, we
compared co-pMG and pMac using Proteome Profiler for
102 cytokines with and without maximal activation
(LPS/interferon-g [IFNg], Table S2). Differentially ex-
pressed cytokines were then selected for a more detailedFigure 4. iPSC Co-culture Microglia Express Relevant Protein Mar
(A) Flow cytometry of cells differentiated from one line (SFC856-03-0
pMacPre were differentiated for 14 days to pMac, pMGL, or co-cultured
cell suspension of the co-culture or isolated with CD11b beads before
(B) Expression of surface markers (three genetic backgrounds, lines SB
co-cultures at 2, 7, 10, and 14 days. To remove obviously non-myeloi
cytometry data. Error bars denote SEM.
See Figure S7 for FSC/SSC gating and additional cytometry data.investigation using Luminex multiplex array, with super-
natants from pMac, pMGL, co-pMG, and pNeuron, with
or without LPS/IFNg stimulation (Figure 7). There was
broad correspondence across Proteome Profiler and Lumi-
nex platforms. Unstimulated neurons secreted only
macrophage migration inhibitory factor (MIF) and
VEGF-A, and when stimulated secreted IL-6, IL-8, and a
subset of chemokines. pMac secreted very few cytokines
constitutively (macrophage inflammatory protein 1a
[MIP1a] and MIPb, CXCL1 and CXCL10, IL-8, and MIF),
but secreted the entire panel of 22 cytokines upon stimu-
lation, in concordance with our previous publication
(which also includes comparison with blood monocyte-
derived macrophages [Jiang et al., 2012]). pMGL had a
higher baseline number of cytokines secreted, and upregu-
lated most cytokines upon stimulation (except IL-23A).
GM-CSF did not account for this difference, as its absence
did not significantly change the cytokine profile of pMGL
(Figure S6).
Co-pMG displayed an overall dampened secretion of
chemokines and cytokines versus pMGL, both constitutive
and induced. Interestingly, SerpinE1 (a serine protease in-
hibitor that inhibits fibrinolysis) and VEGF-A (stimulates
angiogenesis) were significantly higher in activated co-
culture versus monoculture, suggesting that tissue remod-
eling factors are specifically induced in co-culture. Mean-
while, IL-10, which is anti-inflammatory, was significantly
increased in activated co-culture versus monocultures.
Together, these results indicate that co-culture induces spe-
cific anti-inflammatory and pro-remodeling responses not
seen in corresponding monocultures.DISCUSSION
We have established a highly efficient in vitro human iPSC-
derivedmicroglia-neuronco-culturemodel,which recapitu-
lates the ontogenetic development of microglia in vivo.
Co-pMG can be maintained in co-culture, retaining
neuronal maturity and functionality for many weeks. They
express key humanmicroglia-specificmarkers andneurode-
generative disease-relevant genes, upregulate homeostatic
pathways, downregulate pathogen-response pathways,
and exhibit a transcriptional profile similar to that of fetalkers
4, black line is surface marker, filled gray area is isotype control).
with neurons to obtain co-pMG, which were either stained in single-
staining.
AD3-01, SFC840-03-03, SFC856-03-04) in pMacpre, pMac, pMGL, and
d cells from MFI analysis, we set a gate to FL1, FL2, and FL4 for all
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Figure 5. Co-culture with Neurons Promotes iPSC-Microglial Motility
Macrophages and co-culture microglia were imaged every 5 min for 5 hr (two videos each of three cultures i.e., six replicates per
condition).
(A) co-pMG expressing RFP to enable identification in co-culture. Scale bar, 200 mm.
(B–D) Tracks of co-culture microglia (co-pMG; B), compared with cells on tissue-culture plastic: pMGL (C) and pMac (D).
j(E) Accumulated distance.
(F) Euclidian distance (distance in a straight line, start to end).
Error bars represent SD. Statistical analysis by Tukey’s multiple comparisons test. *p < 0.05, ***p < 0.001, ****p < 0.0001; n.s., not
significant. See also Movies S2, S3, andS4.microglia. Co-pMG are phagocytic, adopt a highly dynamic
ramified microglia-like morphology, upon activation dis-
play an activated morphology, and release a battery of
microglia-relevant cytokines, with co-culture promoting a1736 Stem Cell Reports j Vol. 8 j 1727–1742 j June 6, 2017more anti-inflammatory and pro-remodeling cytokine res-
ponse than corresponding monocultures. This shows the
relevance of using co-culture to examine direct and para-
crine microglia-neuronal interactions.
Since primary human microglia can only be obtained
from fresh brain material, previous efforts have been
made by others to develop methods for deriving microglia
in vitro. Etemad and colleagues used human blood mono-
cytes as the starting point (Etemad et al., 2012; Ohgidani
et al., 2014), but it is now known that this pathway poorly
recapitulates microglia ontogenesis and that blood is not a
limitless source of cells, unlike PSCs. Beutner et al. (2013)
described a method for deriving microglia frommouse em-
bryonic stem cells, and, using the same methodology,
Almeida et al. (2012) derived microglia from human iPSCs.
However, this method directs the EBs through a neuronal
differentiation pathway and thus does not replicate yolk
sac myelopoiesis. Moreover, these cells do not express a
convincing microglia signature (Butovsky et al., 2014; Me-
lief et al., 2012). Schwartz et al. (2015) recently successfully
seeded iPSCmacrophages into 3D iPSC-neuronal structures
for toxicity testing, but did not characterize the resulting
cells extensively.
In 2008, we derived human PSC macrophages using a
very simple methodology without OP9 feeders (Karlsson
et al., 2008), which we subsequently adapted to a fully
defined, robust serum-free protocol (van Wilgenburg
et al., 2013), now widely used by others (Aflaki et al.,
2014; Alasoo et al., 2015; Gupta et al., 2016). Our own
work (Buchrieser et al., 2017) and that of others (Hoeffel
et al., 2015) indicates that this protocol produces MYB-in-
dependent myeloid cells, recapitulating an embryonic
ontogeny, and lineage-tracking studies in mouse have
demonstrated that microglia derive from primitive, yolk
sac macrophages that migrate into the developing brain
(Ginhoux et al., 2010, 2013). Together, this provides a
rationale for deriving PSC microglia, using PSC macro-
phages as a starting point and then skewing them toward
a microglial phenotype. During the drafting of this manu-
script, three protocols along these general principles have
been published (Abud et al., 2017; Muffat et al., 2016;
Pandya et al., 2017). Where our analyses overlap, there
is broad consensus. However, only our protocol has direct
evidence by gene knockout for producing MYB-indepen-
dent primitive macrophages (Buchrieser et al., 2017).
It is robust and efficient: time frame 1 month, versus
2 months for Muffat et al. (2016); yield 10–43 per starting
iPSC for our protocol, versus 0.5–4 for Muffat et al. (2016)
and Pandya et al. (2017); manipulation consisting of
once-weekly feeding of differentiation cultures in flasks,
simple supernatant harvest of pure precursors, and mul-
tiple harvests possible, versus sequential trituration/re-
plating steps for Muffat et al. (2016), fluorescence-acti-
vated cell (FAC) sorting/plating on astrocytes/second
FAC sorting for Pandya et al. (2017), and low oxygen con-
centrations/several replatings/five different cytokine cock-
tails/FAC sorting progenitors for Abud et al. (2017). Ourmicroglia medium avoids B27, which contains cortisone,
SOD, and catalase (likely to compromise microglia func-
tion). Muffat et al. (2016) characterized their iPSC micro-
glia in monoculture, briefly assessing co-culture, and Pan-
dya et al. (2017) characterized their iPSC microglia in
monoculture following isolation from astrocytes. We
have extensively characterized iPSC microglia in co-cul-
ture with iPSC cortical neurons, where cells have highly
ramified, dynamic characteristics, and compared directly
to the intermediate and parallel monoculture stages of dif-
ferentiation. This reveals that while key microglia genes
are expressed in co-pMG, they are often also expressed
in pMacpre, pMac, and pMGL, indicating that such genes
may be features of primitive macrophages rather than be-
ing microglia specific, and that comparison only with
blood monocytes/macrophages does not give a complete
interpretation. Finally, we show that co-culture induces
a unique cytokine profile which is not the sum of
monocultures.
There is a fast-growing interest in microglia, as they
are increasingly implicated in neurodegenerative disease,
neurodevelopmental disorders, and in neuropathic pain.
Our iPSC microglia transcribe key genes involved in AD,
PD, and MND. Several other disease-associated genes,
including LRRK2, would be expected to be upregulated
upon microglial stimulation (reviewed in Lee et al.,
2017). Many of these genes are likely involved in phago-
cytosis and processing of misfolded proteins and of dying
neurons (common features of these diseases), and in
generating inappropriate chronic cytokine responses
that exacerbate neuronal damage, creating a destructive
cycle. Human iPSC microglia models enable study of
these gene products at their correct gene dosage, in an
authentic human in vitro system. Some of these func-
tions and disease-relevant genes can be studied in the
monoculture conditions detailed here, but others,
involving crosstalk between microglia and neurons,
such as paired receptor engagement, paracrine signaling,
damage responses, synaptic surveillance, and pruning,
will be better studied using the co-culture model we
have described. The system is also amenable to scaling
for the development of drug-screening assays to identify
compounds that can improve microglial homeostatic
clearance functions and dampen chronically activated
microglia.EXPERIMENTAL PROCEDURES
Consent for Use of Human Material
All human material (iPSCs, adult blood, fetal and adult microglia)
was obtained with informed consent and with the approval of
the relevant institutions (see Supplemental Information for full
details).Stem Cell Reports j Vol. 8 j 1727–1742 j June 6, 2017 1737
Figure 6. LPS Induces Inflammatory Morphology and Clustering in Co-culture Microglia
(A–D) Microglial morphology displayed as inverted LUT black and white images of RFP-iPSC microglia in co-culture. (A) Images (co-culture
day 12) every 5 min for 10 hr. Representative images of LPS-stimulated co-pMG are shown at 0, 5, and 10 hr. (B) co-pMG clustering on LPS
stimulation shown by cell tracking. (C–E) Quantitative analysis (two videos each of three cultures, i.e., six replicates per condition).
Images were taken on co-culture on day 14 every 5 min for 20 hr. (C) Representative images of 0-hr and 20-hr time points; Bottom panel:
area in the black square magnified to show microglial morphology: unstimulated co-pMG show no obvious changes in morphology during
imaging period, but on LPS stimulation some microglia cluster, adopting more ameboid morphology with shorter processes and higher
area-to-perimeter ratio, representative of a pro-inflammatory phenotype (black arrows). (D) Distance between microglia clustering upon
(legend continued on next page)
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Macrophage Differentiation
See Supplemental Experimental Procedures for details of cells and
assays used. iPSCs were differentiated to macrophages as previ-
ously described (van Wilgenburg et al., 2013). In short, 3 3 106
iPSCswere seeded into an Aggrewell 800well (STEMCELLTechnol-
ogies) to form EBs, in mTeSR1 and fed daily with medium plus
50 ng/mL BMP4 (Peprotech), 50 ng/mL VEGF (Peprotech), and
20 ng/mL SCF (Miltenyi Biotec). Four-day EBs were then differen-
tiated in either 6-well plates (15 EBs/well), T75 (75 EBs), or T175
flasks (150 EBs) in X-VIVO15 (Lonza), supplemented with
100 ng/mL M-CSF (Invitrogen), 25 ng/mL IL-3 (R&D), 2 mM Glu-
tamax (Invitrogen), 100 U/mL penicillin and 100 mg/mL strepto-
mycin (Invitrogen), and 0.055 mM b-mercaptoethanol (Invitro-
gen), with fresh medium added weekly. pMacpre emerging into
the supernatant after approximately 1 month were collected
weekly and differentiation cultures replenished with fresh me-
dium. Harvested cells were strained (40 mm, Corning) and used:
either directly as pMacpre; or plated onto tissue-culture treated
plastic or glass coverslips at 100,000 per cm2 and differentiated
for 7 days or more to pMac in X-VIVO15 with 100 ng/mL M-CSF,
2 mM Glutamax, 100 U/mL penicillin, and 100 mg/mL strepto-
mycin; or co-cultured with iPSC-derived neurons.Neuronal Differentiation
iPSCs were differentiated to cortical neuron progenitors (NPCs)
(Shi et al., 2012) with the following modifications: feeder-free
iPSCs were plated onto Matrigel-coated 6-well plates, with neural
induction for 12 days using dual SMAD inhibition; after replating
the neuroepithelial sheet at day 12 using dispase, 20 ng/mL fibro-
blast growth factor 2 (FGF2) was added to neural maintenance me-
dium (NMM) on days 13–17, newly formed rosettes were dispased
on days 17–18, and stocks of NPC were frozen at days 25–30.Microglia Medium
In pilot experiments, macrophages were differentiated in three
different basal media (XVIVO15, RPMI, or Advanced DMEM/
F12 + N2 supplement) supplemented with 2 mM Glutamax,
100 U/mL penicillin and 100 mg/mL streptomycin, and 0.055 mM
b-mercaptoethanol, with combinations of 100 ng/mLM-CSF (Invi-
trogen), 100 ng/mL IL-34 (Peprotech or Biolegend), and 10 ng/mL
GM-CSF (Invitrogen). ADMEM/F12 + N2 supplement +100 ng/mL
IL-34 + 10 ng/mL GM-CSF microglia medium was used for all
further experiments (for details see Table S2).Microglia-Neuron Co-culture
NPCs were thawed, centrifuged (200 3 g, 10-fold volume NMM),
and plated onto Matrigel in NMM supplemented with 10 mmol/L
Y-27632 and 20 ng/mL FGF2. Medium was replaced the next day
and every other day thereafter with NMM. After 7 days they were
dissociated to single cells with StemPro Accutase (STEMCELL),
added to their final Matrigel-coated format (Corning 96-well orstimulation is evidenced by a leftward shift of the plot after 10 hr a
assessors for number of microglia with activated morphology. Stat
significant; *p < 0.05.
Scale bars, 200 mm. See also Movie S5.6-well plate, or Ibidi 8-well slide) at 100,000 cells/cm2 and cultured
for 14 days in NMM. pMacpre were resuspended in microglia me-
dium, added at 100,000 cells/cm2 to neurons, and co-cultured for a
minimum 14 days before assaying.
Statistics
GraphPad Prism was used for statistical analysis. One-way ANOVA
and Dunnett’s multiple comparisons, Tukey’s multiple compari-
sons, or paired two-tailed t test (for single comparisons) were
used as indicated. Values are indicated in figures as *p < 0.05,
**p < 0.01, ***p < 0.001, ****p < 0.0001, and n.s. (not significant).
Numbers in parentheses are (mean ± SEM, n).
ACCESSION NUMBERS
The accession number for the Illumina HT12v4 expression array
datasets reported in this paper is GEO: GSE89795.
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Figure 7. Cytokine Profiles of Co-culture versus Monocultures
Eighteen-hour supernatants from cells stimulated with or without LPS/IFNg were assayed with a Luminex multiplex assay. DMEM/F12/N2-
based microglia medium was used for monoculture (pMGL), co-culture (co-pMG), and neuron-only culture (pNeuron); standard XVIVO15-
based macrophage medium was used for pMac. Medium alone contained negligible levels of all cytokines tested. Supernatants from lines:
SBAD3-01 neurons ± SFC180-01-01, SFC840-03-03, and SFC856-03-04 macrophages/microglia.
(A) Unstimulated cells.
(B) LPS/IFNg-stimulated cells.
Mean ± SD, three genetic backgrounds. Asterisks indicate significant difference between co-pMG and pMGL by two-tailed paired t test.
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. See Table S2 for further factors tested with pMac and co-pMG, and Figure S6 for effect
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